Should prophylaxis for Pneumocystis jirovecii pneumonia be considered in patients with a CD4+ count higher than 200 cells/μl?

AIDS. 2015 Nov 28;29(18):2533-4. doi: 10.1097/QAD.0000000000000881.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antifungal Agents / administration & dosage*
  • CD4 Lymphocyte Count
  • Chemoprevention / methods*
  • Female
  • HIV Infections / complications*
  • HIV Infections / pathology*
  • Humans
  • Pneumocystis carinii / drug effects*
  • Pneumonia, Pneumocystis / prevention & control*

Substances

  • Antifungal Agents